Features of prescription drug monitoring programs associated with reduced rates of prescription opioid-related poisonings

被引:50
作者
Pauly, N. J. [1 ]
Slavova, S. [2 ]
Delcher, C. [3 ]
Freeman, P. R. [1 ]
Talbert, J. [1 ]
机构
[1] Univ Kentucky, Coll Pharm, Inst Pharmaceut Outcomes & Policy, 789 South Limestone, Lexington, KY 40536 USA
[2] Univ Kentucky, Coll Publ Hlth, Dept Biostat, 333 Waller Ave,Suite 242, Lexington, KY 40504 USA
[3] Univ Florida, Dept Hlth Outcomes & Policy, 2004 Mowry Rd,Suite 2237,POB 100177, Gainesville, FL 32610 USA
关键词
Opioid; Policy; Evaluation; Poisoning; Prescription drug monitoring program; UNITED-STATES; DEATH RATES; RETROSPECTIVE ANALYSIS; EMERGENCY-DEPARTMENT; OVERDOSE; LAWS; IMPLEMENTATION; REDUCTIONS; ANALGESICS; EVOLUTION;
D O I
10.1016/j.drugalcdep.2017.12.002
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: The United States is in the midst of an opioid epidemic. In addition to other system-level interventions, all states have responded during the crisis by implementing prescription drug monitoring programs (PDMPs). This study examines associations between specific administrative features of PDMPs and changes in the risk of prescription opioid-related poisoning (RxORP) over time. Methods: This longitudinal, observational study utilized a 'natural experiment' design to assess associations between PDMP features and risk of RxORP in a nationally-representative population of privately-insured adults from 2004 to 2014. Administrative health claims data were used to identify inpatient hospital admissions and emergency department visits related to RxORP. Generalized estimating equation Poisson regression models were used to examine associations between specific PDMP features and changes in relative risk (RR) of RxORP over time. Results: In adjusted analyses, states without PDMPs experienced an average annual increase in the rate of RxORP of 9.51% over the study period, while states with operational PDMPs experienced an average annual increase of 3.17%. The increase in RR of RxORP over time in states with operational PDMPs was significantly less than increases in states without PDMPs. States with specific features, including those that monitored more schedules or required more frequent data reporting, experienced stronger protective effects on the RR of RxORP over time. Conclusion: This study examined associations between specific PDMP features and RxORP rates in a nationally representative population of privately-insured adults. Results of this study may be used as empirical evidence to guide PDMP best practices.
引用
收藏
页码:26 / 32
页数:7
相关论文
共 43 条
[1]  
[Anonymous], 2012, NATURAL EXPT SOCIAL
[2]  
[Anonymous], 2016, WAVE METRICS VERSION
[3]  
[Anonymous], J PHARM CARE PAIN S
[4]  
[Anonymous], 2013, PRESCR DRUG OV DAT S
[5]   The evolution of prescription drug monitoring programs [J].
Ashburn, Michael A. .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 (07) :852-853
[6]   Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians [J].
Bao, Yuhua ;
Pan, Yijun ;
Taylor, Aryn ;
Radakrishnan, Sharmini ;
Luo, Feijun ;
Pincus, Harold Alan ;
Schackman, Bruce R. .
HEALTH AFFAIRS, 2016, 35 (06) :1045-1051
[7]   Prescription Drug Monitoring and Dispensing of Prescription Opioids [J].
Brady, Joanne E. ;
Wunsch, Hannah ;
DiMaggio, Charles ;
Lang, Barbara H. ;
Giglio, James ;
Li, Guohua .
PUBLIC HEALTH REPORTS, 2014, 129 (02) :139-147
[8]  
Centers for Disease Control and Prevention, 2012, CDC GRAND ROUNDS PRE
[9]   The Changing Face of Heroin Use in the United States A Retrospective Analysis of the Past 50 Years [J].
Cicero, Theodore J. ;
Ellis, Matthew S. ;
Surratt, Hilary L. ;
Kurtz, Steven P. .
JAMA PSYCHIATRY, 2014, 71 (07) :821-826
[10]   Geographic variation in the prescription of schedule II opioid analgesics among outpatients in the United States [J].
Curtis, Lesley H. ;
Stoddard, Jennifer ;
Radeva, Jasmina I. ;
Hutchison, Steve ;
Dans, Peter E. ;
Wright, Alan ;
Woosley, Raymond L. ;
Schulman, Kevin A. .
HEALTH SERVICES RESEARCH, 2006, 41 (03) :837-855